跳到主要內容區塊
定位點

2017 National Report of the Assisted Reproductive Technology Summary in Taiwan

  • 點閱次數:點閱次數:496
  • 更新日期:更新日期:2025/04/01
  • 發布日期:發布日期:2024/12/09
The Assisted Reproduction Act (ARA) was promulgated and implemented on March 21, 2007 with the aim to perfect the development of assisted reproduction technology (hereinafter referred to the “ART”) and to safeguard the rights of infertile couples, children born under assisted reproduction and donors, as well as to uphold public ethics and health. According to the provisions of Article 27 of the ARA, assisted reproduction institutions are obliged to report relevant information regarding the number of recipient patients undergoing treatment, success rates, causes of infertility, and the ART adopted. The competent authority shall establish an assisted reproduction database and periodically conduct statistical analyses as well as publish updated data accordingly.

Relevant laws and regulations governing the management of the practices and database of assisted reproduction in Taiwan has been gradually formulated since 1995. By early 1998, a total of 48 assisted reproduction institutions were established in Taiwan; by April, 2019, the number of licensed medical institutions had reached 85 in total. In accordance with the provisions of the ARA, these medical institutions are required to apply for approval from the competent authority to engage in ART practices and provision of acceptance, storage and provision of donated gametes. In order to maintain the quality of ART performed in medical institutions, the Health Promotion Administration, Ministry of Health and Welfare (hereinafter referred to the “HPA”) regularly carries out permit reviews on all licensed assisted reproduction institutions.

This report focuses on the statistical analysis of cases that had been treated in 84 assisted reproductive institutions in Taiwan (2017). Chapter 1 briefly introduces the definitions of assisted reproductive methods and treatment cycles. Chapter 2 presents the statistics for all treatment cycles, including data from nondonor gametes and embryos as well as sperm/eggs recipients. Chapter 3 conducts an analysis of data from nondonor gametes and embryos. Chapter 4 presents an analysis of the trends in the ART practices from 1998-2017.
 

您可能會喜歡

看完本篇主題後,您的感覺如何?